Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a) [Phase 2]
Phase 2 clinical trial to evaluate Kylo-11 in patients with atherosclerotic cardiovascular disease and elevated lipoprotein(a) is currently …
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors [NA]
A Rutgers-sponsored clinical trial aims to improve coordination between cancer care teams and primary care for complex cancer survivors. The…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: The Genetic, Protein, and Lipid Basis of Variation in Cholesterol Efflux
The document reports completion and posting of results for a clinical trial investigating genetic, protein, and lipid factors affecting chol…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Impact of the Corrie Lipids Digital Health Program on Lipid Optimization [NA]
An ongoing Johns Hopkins University study is evaluating the Corrie Lipids digital health program to optimize lipid management and reduce LDL…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Penn Medicine Healthy Heart [NA]
A Penn Medicine clinical trial called 'Healthy Heart' is currently recruiting and targets individuals with hypertension and hyperlipidemia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2026-03-11FDA Approved: FENOFIBRIC ACID — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for Fenofibric acid by Alembic Pharmaceuticals Limited.
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Evaluating the Effectiveness of a Multi-level Health-Related Social Needs Initiative [NA]
A Vanderbilt-led clinical trial is evaluating a multi-level health-related social needs program for people with Type 2 diabetes mellitus and…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome [Phase 3]
Phase 3 trial evaluating Obicetrapib/ezetimibe 10 mg fixed-dose combination or Obicetrapib 10 mg daily on top of guideline-recommended lipid…
-
FDA approval · 2026-03-05FDA Approved: CHOLESTYRAMINE — Original Application (Micro Labs Limited)
FDA approves Micro Labs Limited's original application for CHOLESTYRAMINE, a generic bile acid sequestrant used to lower cholesterol in pati…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Imaging the Pathogenesis of Cerebral Small Vessel Disease
A Johns Hopkins University trial is examining imaging-based mechanisms underlying cerebral small vessel disease to better understand its pat…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial [Phase 2]
A Phase 2 clinical trial titled 'Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders' is currently recruiting. The study i…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C) [Phase 1]
This is a Phase 1 clinical trial update for STX-1150 in participants with elevated LDL cholesterol/high cholesterol, currently not recruitin…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: triPle Oral thERapy With Bempedoic Acid vs uSual Care in Early Lipid Management of Patients With acUte coronAry synDromE [Phase 3]
Phase 3 trial evaluating triPle oral therapy including bempedoic acid for early lipid management in patients with acute coronary syndrome; t…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Duke Cardiometabolic Prevention Clinic's Impact on High-risk Cardiovascular Patients With Uncontrolled Risk Factors [NA]
A Duke University trial evaluating cardiometabolic prevention strategies for high-risk cardiovascular patients with uncontrolled risk factor…
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: A Long-term Trial of ETC-1002 in Patients With Hyper-LDL Cholesterolemia [Phase 3]
Phase 3 long-term trial results for ETC-1002 (bempedoic acid) in adults with hypercholesterolemia were completed, with results posted in Feb…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: A First In Human (FIH) Study to Learn if Different Doses of ALN-ANG3 Are Safe and Well Tolerated in Healthy Adults [Phase 1]
First-in-human Phase 1 trial to assess safety and tolerability of multiple doses of ALN-ANG3 in healthy adults, including individuals with h…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Evaluation of the Effect of Lomitapide Treatment on Major Adverse Cardiovascular Events (MACE) in Patients With Homozygous Familial Hypercholesterolemia
This clinical trial update examines the effect of lomitapide on major adverse cardiovascular events in patients with homozygous familial hyp…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food [NA]
A pilot clinical trial investigating Bottarga supplementation is currently recruiting to evaluate effects on metabolic conditions.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Enhancing Mental and Physical Health of Women Veterans [NA]
ClinicalTrials.gov entry describes a VA study to enhance mental and physical health in women veterans, targeting cardiovascular risk factors…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Investigating The Potential Of A Hay-Aged Cheese To Reduce Cholesterol As Mediated By Changes In The Gut Microbiome [NA]
An ongoing clinical trial is evaluating whether hay-aged cheese can lower cholesterol by modifying the gut microbiome.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Prospective Exploratory Study on the Comprehensive Application Effectiveness of Exercise Prescription Decision Support Tools in the Management of Patients With "Four Highs" (Hypertension, Hyperglycemia, Hyperlipidemia, Hyperuricemia) [NA]
A prospective exploratory study evaluating the effectiveness of an exercise prescription decision support tool for managing the four high co…
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia [Phase 2]
Phase 2 clinical trial update showing results for SHR-1918 in hyperlipidemia, detailing efficacy and safety outcomes.
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemic [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of SHR-1918 in patients with hyperlipidemia has completed.
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia [Phase 3]
A Phase 3 clinical trial is evaluating the efficacy and safety of SHR-1918 in patients with hyperlipidemia and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV [EARLY_Phase 1]
An early-phase 1 trial comparing doravirine to integrase inhibitors on a fixed backbone of emtricitabine and tenofovir alafenamide in HIV-1 …